Literature DB >> 22061839

An overview: in vitro models of HCV replication in different cell cultures.

Huma Tariq1, Sobia Manzoor, Fahed Parvaiz, Farakh Javed, Kaneez Fatima, Ishtiaq Qadri.   

Abstract

Although much of productive research has been conducted in the field of molecular virology of Hepatitis C virus (HCV) regarding its genes, gene functions and proteins, development of an efficient cell culture model for its replication remained a focused area. Focus has been directed to establish HCV in vitro replication system. This replication system should mimic its intrahepatic pathogenesis so that antivirals should be screened and in vitro gene profiling of HCV induced pathogenesis should be worked out. Since 1990 various experimental approaches and strategies have been utilized in phase of development of a robust replication model for HCV, and success has been reported for a few genotypes. Still the work is going on to have more success in availing such robust replication models for all the genotypes. This will help to have a common antiviral strategy against HCV induced pathogenesis involving any genotype or subtype.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22061839     DOI: 10.1016/j.meegid.2011.10.009

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  8 in total

1.  Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages.

Authors:  Yuan Liu; Wenbo Wang; Ziying Zou; Zonghai Hu; Quanshui Fan; Jie Xiong
Journal:  Dig Dis Sci       Date:  2018-12-10       Impact factor: 3.199

2.  The HepaRG cell line: a valuable in vitro tool for hepatitis virus infection studies.

Authors:  Liesbeth Ceelen; Marusya Lieveld; Ramses Forsyth; Mathieu Vinken
Journal:  Hepatol Int       Date:  2013-02-14       Impact factor: 6.047

3.  Novel permissive cell lines for complete propagation of hepatitis C virus.

Authors:  Mai Shiokawa; Takasuke Fukuhara; Chikako Ono; Satomi Yamamoto; Toru Okamoto; Noriyuki Watanabe; Takaji Wakita; Yoshiharu Matsuura
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

4.  A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease.

Authors:  Chi-Chen Yang; Han-Shu Hu; Ren-Huang Wu; Szu-Huei Wu; Shiow-Ju Lee; Weir-Torn Jiaang; Jyh-Haur Chern; Zhi-Shun Huang; Huey-Nan Wu; Chung-Ming Chang; Andrew Yueh
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

5.  Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes.

Authors:  Moritz Kleine; Marc Riemer; Till Krech; Daphne DeTemple; Mark D Jäger; Frank Lehner; Michael P Manns; Jürgen Klempnauer; Jürgen Borlak; Hueseyin Bektas; Florian W R Vondran
Journal:  PLoS One       Date:  2014-07-07       Impact factor: 3.240

6.  Detection of hepatitis C virus (HCV) negative strand RNA and NS3 protein in peripheral blood mononuclear cells (PBMC): CD3+, CD14+ and CD19+.

Authors:  Agnieszka Pawełczyk; Natalia Kubisa; Joanna Jabłońska; Iwona Bukowska-Ośko; Kamile Caraballo Cortes; Maria Fic; Tomasz Laskus; Marek Radkowski
Journal:  Virol J       Date:  2013-11-26       Impact factor: 4.099

7.  A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.

Authors:  Khanit Sa-Ngiamsuntorn; Adisak Wongkajornsilp; Phetcharat Phanthong; Suparerk Borwornpinyo; Narisorn Kitiyanant; Wasun Chantratita; Suradej Hongeng
Journal:  Virol J       Date:  2016-04-05       Impact factor: 4.099

8.  Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking.

Authors:  Hongliang Wang; Jeffrey W Perry; Adam S Lauring; Petra Neddermann; Raffaele De Francesco; Andrew W Tai
Journal:  Gastroenterology       Date:  2014-02-08       Impact factor: 22.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.